Beristain GI, Juárez HF, Pensado PLE, Sotelo RR, Rivera RRM

Language: Spanish
References: 13
Page: 76-82
PDF size: 528.31 Kb.

ABSTRACT

Objective. Establish an overview of the role imaging plays in the diagnosis of malignant pleural mesothelioma (MPM) and identify clinical, epidemiological, geographic, occupational, and image data, biopsy method, and histopathological reporting.
Material and methods. We reviewed 154 clinical and radiological files from patients with histopathological diagnosis of malignant pleural mesothelioma who received care at Instituto Nacional de Enfermedades Respiratoria (INER) in Mexico City in the period from 2005 through 2011, and performed a percentage analysis of the data obtained.
Results. Of the 154 patients included, 110 (71.4%) were males. Dyspnea was the primary symptom in 137 patients (88.9%). All had chest x-rays with pleural effusion. Computed tomography confirmed pleural effusion in 154 patients and pleural thickening was reported in 100 (65%). Chest ultrasound was indicated and performed for only 7 patients (4.5%). Imageguided biopsies were taken from 19 patients. The histopathological report revealed that in 140 patients the histological el type of MPM was epithelial.
Conclusions. Males continue to be the gender most affected by malignant pleural mesothelioma. Dyspnea and chest pain are the primary symptoms. Simple chest x-ray plays a fundamental role in the initial diagnosis of MPM. Tomography is the image method indicated for staging. Pleural biopsy guided by ultrasound or tomography is currently underused.

REFERENCES

1. Eastwood EH, Martin JP. A case of primary tumour of the pleura. Lancet 1921;198:167-214.

2. Heilo A, Stenwig AE, Solheim OP. Malignant Pleural Mesothelioma: USguided Histologic Core-Needle Biopsy. Radiology 1999;211:657-659.

3. Martinez B, Lavat M, Alvarez N. Mesotelioma. Revista del Tórax 2005;13:43-47.

4. Pérez GC, Vargas M, Torre BL. Mesotelioma pleural. Similitudes clínicoradiológicas entre estirpes. Rev Med Inst Mex Seguro Soc 2008;46(5):561-566.

5. Tyszko SM, Marano GD, Tallaksen RF, Gyure KA. Best Cases from the AFIP. Malignant Mesothelioma. RG 2007;27:259-264.

6. Villalba Caloca J, Martínez Heredero R. Frecuencia del mesotelioma maligno. Revisión Clínica. Experiencia en el Instituto Nacional de Enfermedades Respiratorias durante 1998-2002. Rev Inst Nal Enf Resp Mex 2003;16(3):150-157.

7. Barrera RR, Chavarría GJ, Morales FJ. Mesotelioma maligno: Experiencia clínico-patológica de 247 casos. Rev Chil Enf Respir 2010;26:134-140.

8. Fernández IB, Michel FJ. Mesotelioma pleural maligno. An Sist Sanit Navar 2005;28(Suppl 1):29-35.

9. Havelock T, Teoh R, Laws D, Gleeson F. Pleural procedures and thoracic ultrasound: British Thoracic Society pleural disease guideline 2010. Thorax 2010;65(Suppl 2):ii61-ii76.

10. Doust BD, Baum JK, Maklad NF, Doust VL. Ultrasonic Evaluation of Pleural Opacities. Radiology 1975;114:135-140.

11. Martín JJ. Técnicas de biopsia en patología pleural. Neumosur 2006;18,3:137-142.

12. Liao WY, Chen MZ, Chang YL, y col. US-guided Transthoracic Cutting Biopsy for Peripheral Thoracic Lesions Less than 3 cm in Diameter. Radiology 2000;217:685-691.

13. Wang ZF, Reddy GP, Gotway MB, y col. Malignant Pleural Mesothelioma: Evaluation with CT, MR Imaging and PET. RG 2004;24:105-119.